Product Images Vyleesi
View Photos of Packaging, Labels & Appearance
- Figure 1 - vyl00 0004 01
- Figure 2 - vyl00 0004 02
- Figure 3 - vyl00 0004 03
- Figure - vyl00 0004 04
- Figure - vyl00 0004 05
- Figure - vyl00 0004 06
- Figure - vyl00 0004 07
- Figure - vyl00 0004 08
- Figure - vyl00 0004 09
- Figure - vyl00 0004 10
- Figure - vyl00 0004 11
- Figure - vyl00 0004 12
- Figure - vyl00 0004 13
- Figure - vyl00 0004 14
- Figure - vyl00 0004 15
- Figure - vyl00 0004 16
- Principal Display Panel – 4 Syringe Carton Label - vyl00 0004 18
- Principal Display Panel – Syringe Label - vyl00 0004 19
Product Label Images
The following 18 images provide visual information about the product associated with Vyleesi NDC 0713-0897 by Cosette Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - vyl00 0004 01
Figure 2 - vyl00 0004 02
Figure 3 - vyl00 0004 03
Figure - vyl00 0004 04
This text provides instructions for using Vyleesi, also known as bremelanotide. It contains 1.75 mg of the medication in 0.3 mL and is intended for subcutaneous use only.*
Figure - vyl00 0004 05
This appears to be a set of instructions for checking expiration dates and verifying completion of injections using a view window and colored tips. The expiration date should be checked when there is a gray tip showing in half of the view window. When the view window turns purple and the tip is also purple, it indicates that the injection is complete.*
Figure - vyl00 0004 06
Figure - vyl00 0004 07
Figure - vyl00 0004 08
Figure - vyl00 0004 09
Figure - vyl00 0004 10
Figure - vyl00 0004 11
Figure - vyl00 0004 12
Figure - vyl00 0004 13
Figure - vyl00 0004 14
Figure - vyl00 0004 15
Dispose of the autoinjector by throwing it away. Proper disposal of medical devices is important for safety and environmental reasons.*
Figure - vyl00 0004 16
This is a promotional material for pharmaceuticals marketed by Cosette Pharmaceuticals, Inc. The contact information includes a phone number (1-800-922-1038) and website (www.cosettepharma.com). The document also includes reference numbers such as PCR-750-19314 and 18-0897CP1. It was issued in March 2024.*
Principal Display Panel – 4 Syringe Carton Label - vyl00 0004 18
Principal Display Panel – Syringe Label - vyl00 0004 19
This is a description for Bremelanotide injection, a medication typically used for subcutaneous administration. The product is available in a single-dose autoinjector containing 175mg/0.3 mL. It is important to administer no more than 1 dose per 24 hours or 8 doses per month. It is advised to store the medication at or below 25°C, avoiding freezing and exposure to light. The specific NDC code for this product is NDC0713-0897-06. Marketed by Coserte Pharmaceuticals Inc., this treatment can provide therapeutic benefits when used as directed.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
